Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 7 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1572904 |
| 301 | 3 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY//LEVOSIMENDAN//PHARMACOLOGY & PHARMACY | 41522 |
| 1503 | 2 | NEBIVOLOL//CARVEDILOL//BETA BLOCKERS | 7786 |
| 25636 | 1 | BISOPROLOL//CLINICAL PHARMACOKINETIC TRIAL//54 SHOGOIN KAWARA CHOSAKYO KU | 298 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | BISOPROLOL | authKW | 328158 | 10% | 11% | 29 |
| 2 | CLINICAL PHARMACOKINETIC TRIAL | authKW | 211521 | 1% | 100% | 2 |
| 3 | 54 SHOGOIN KAWARA CHOSAKYO KU | address | 105761 | 0% | 100% | 1 |
| 4 | BETA 1 ADRENERGIC RECEPTOR ANTAGONIST | authKW | 105761 | 0% | 100% | 1 |
| 5 | BETA 1 SELECTIVE ADRENOCEPTOR BLOCKADE | authKW | 105761 | 0% | 100% | 1 |
| 6 | BETA ADRENOCEPTOR BLOCKERS DRUG DRUG INTERACTIONS | authKW | 105761 | 0% | 100% | 1 |
| 7 | BETA BLOCKING DRUG | authKW | 105761 | 0% | 100% | 1 |
| 8 | BISOPROLOL MILD TO MODERATE HYPERTENSION | authKW | 105761 | 0% | 100% | 1 |
| 9 | BLOOD PRESSURE AT REST | authKW | 105761 | 0% | 100% | 1 |
| 10 | BRADICARDIA | authKW | 105761 | 0% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Pharmacology & Pharmacy | 4103 | 67% | 0% | 200 |
| 2 | Cardiac & Cardiovascular System | 1371 | 27% | 0% | 81 |
| 3 | Chemistry, Medicinal | 349 | 11% | 0% | 32 |
| 4 | Medicine, General & Internal | 120 | 11% | 0% | 32 |
| 5 | Medicine, Research & Experimental | 113 | 8% | 0% | 25 |
| 6 | Toxicology | 22 | 3% | 0% | 10 |
| 7 | Peripheral Vascular Diseases | 18 | 3% | 0% | 9 |
| 8 | Chemistry, Multidisciplinary | 5 | 6% | 0% | 18 |
| 9 | Engineering, Chemical | 2 | 3% | 0% | 8 |
| 10 | Medical Informatics | 1 | 0% | 0% | 1 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | 54 SHOGOIN KAWARA CHOSAKYO KU | 105761 | 0% | 100% | 1 |
| 2 | DEXA MEDICA GRP | 105761 | 0% | 100% | 1 |
| 3 | TOKUSHIMA ANALYT | 105761 | 0% | 100% | 1 |
| 4 | CITY CLIN HOSP 3 | 52879 | 0% | 50% | 1 |
| 5 | FSB EDUC SCI MED | 35252 | 0% | 33% | 1 |
| 6 | TREATMENT REHABIL NISKA BANJA | 26439 | 0% | 25% | 1 |
| 7 | BIOAVAI IL BIOEQUIVALENCE | 13218 | 0% | 13% | 1 |
| 8 | VIA ERITREA 62 | 10574 | 0% | 10% | 1 |
| 9 | CARL GUSTAV CARUS KLINIKUM | 7049 | 0% | 7% | 1 |
| 10 | RUSSIAN CARDIOL SCI CLIN COMPLEX | 5034 | 0% | 5% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | JOURNAL OF CARDIOVASCULAR PHARMACOLOGY | 22107 | 16% | 0% | 48 |
| 2 | EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 12431 | 10% | 0% | 29 |
| 3 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 11111 | 7% | 1% | 21 |
| 4 | COEUR ET MEDECINE INTERNE | 7049 | 0% | 7% | 1 |
| 5 | NATURE REVIEWS CHEMISTRY | 6219 | 0% | 6% | 1 |
| 6 | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | 5641 | 5% | 0% | 16 |
| 7 | CARDIOVASCULAR THERAPY AND PREVENTION | 2263 | 1% | 1% | 4 |
| 8 | BRITISH JOURNAL OF CLINICAL PHARMACOLOGY | 1540 | 4% | 0% | 11 |
| 9 | EUROPEAN JOURNAL OF CARDIOLOGY | 1427 | 0% | 1% | 1 |
| 10 | PHARMATHERAPEUTICA | 1335 | 1% | 1% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |